← Leaderboards
Aarash Bordbar
Sinopia Biosciences, Inc.
$10,092,533
Attributed
$11,417,538
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2014–24$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,417,538 · 10
By mechanism
R44$10,186,611 · 5
R43$1,230,927 · 5
Top collaborators
- Travis Nemkov3 shared
Most similar at Sinopia Biosciences, Inc.
Same institution · by research overlap
- Travis Nemkov$2,072,523
Others in their field
Top investigators on “Data Set”
- Lawrence Corey · Fred Hutchinson Cancer Center$424,653,591
- David R. Weir · University Of Michigan At Ann Arbor$412,781,191
- David Heimbrook · Leidos Biomedical Research, Inc.$409,886,450
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$348,905,121
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Research focus
Data SetSafetyBaseSuccessLesionComplexIn VitroMetabolomicsProgramsPharmaceutical PreparationsGenerationsCostAffectMachine LearningGene ExpressionMetabolicData AnalysesComputing MethodologiesDrug DiscoveryCommercializationCaringExposure ToCell PhysiologySystems Biology
Grant awards (17)
Preclinical development of a novel therapeutic for Parkinson's disease$1,282,299
R44 · FY2024 · NS · contact PI
Preclinical development of a novel therapeutic for Parkinson's disease$1,461,860
R44 · FY2023 · NS · contact PI
Preclinical development of a novel therapeutic for Parkinson's disease$99,900
R44 · FY2023 · NS · contact PI
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery$871,587
R44 · FY2022 · GM · contact PI
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery$1,335,997
R44 · FY2021 · GM · contact PI
Preclinical development of a novel therapeutic for Parkinson's disease$577,562
R44 · FY2021 · NS · contact PI
Developing a systems biology platform for predicting, preventing, and treating drug side effects$754,478
R44 · FY2020 · GM · contact PI
Developing a systems biology platform for predicting, preventing, and treating drug side effects$802,538
R44 · FY2019 · GM · contact PI
Improving safety and efficacy of platelet pathogen inactivation techniques through systems biology$224,284
R43 · FY2019 · HL · contact PI
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery$442,427
R43 · FY2018 · GM · contact PI
Improving safety and efficacy of platelet transfusion through systems biology$428,727
R44 · FY2018 · HL · contact PI
Improving safety and efficacy of platelet transfusion through systems biology$1,099,022
R44 · FY2017 · HL · contact PI
Improving red blood cell transfusion through systems biology$443,351
R44 · FY2017 · HL · contact PI
Improving red blood cell transfusion through systems biology$1,029,290
R44 · FY2016 · HL · contact PI
Developing a Systems Biology Platform for Predicting Drug Toxicity and Safety$190,634
R43 · FY2016 · GM · contact PI
Improving safety and efficacy of platelet transfusion through systems biology$223,582
R43 · FY2015 · HL · contact PI
Improving red blood cell transfusion through systems biology$150,000
R43 · FY2014 · HL · contact PI